When.com Web Search

  1. Ad

    related to: Which booster works best against the latest variant?

Search results

  1. Results From The WOW.Com Content Network
  2. New Covid boosters work against the highly mutated BA.2.86 ...

    www.aol.com/news/moderna-says-updated-covid...

    The new Covid boosters appear to work against the BA.2.86 omicron ... Moderna is the first Covid vaccine maker to release data on the effectiveness of the updated booster against the new variant.

  3. A new COVID-19 booster was just approved by the FDA ... - AOL

    www.aol.com/news/covid-19-booster-just-approved...

    Which variants will the new booster protect against? All the new vaccines will be designed to provide better protection against more recent strains, particularly the JN.1 strain that was ...

  4. What Doctors Want You to Know About Getting the New ... - AOL

    www.aol.com/doctors-want-know-getting-covid...

    Doctors share when to get the new COVID-19 shot, its side effects, what variants it protects against, how soon to get a booster after infection, and more.

  5. FDA approves updated Moderna and Pfizer Covid boosters ... - AOL

    www.aol.com/fda-approves-updated-moderna-pfizer...

    An updated Coronavirus booster that targets a new variant is expected to be made available in September ... updated boosters are expected to work well against the BA.2.86 variant – unofficially ...

  6. Pfizer–BioNTech COVID-19 vaccine - Wikipedia

    en.wikipedia.org/wiki/Pfizer–BioNTech_COVID-19...

    The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, [2][33] is an mRNA-based COVID-19 vaccine developed by the German biotechnology company BioNTech. For its development, BioNTech collaborated with the American company Pfizer to carry out clinical trials, logistics, and manufacturing. [45][46] It is authorized for use ...

  7. Oxford–AstraZeneca COVID-19 vaccine - Wikipedia

    en.wikipedia.org/wiki/Oxford–AstraZeneca_COVID...

    The new vaccine would be based on the current Vaxzevria adenoviral vector platform but modified with spike proteins based on the Beta (B.1.351 lineage) variant. [11] Phase II/III trials saw 2849 volunteers participating from UK, South Africa, Brazil and Poland with parallel dosing of both the current Oxford-AstraZeneca vaccine and the variant ...

  8. Sanofi–GSK COVID-19 vaccine - Wikipedia

    en.wikipedia.org/wiki/Sanofi–GSK_COVID-19_vaccine

    The Sanofi–GSK COVID‑19 vaccine is a recombinant protein subunit vaccine containing the SARS-CoV-2 spike protein, which is produced in insect cells via a baculovirus vector. It also includes an adjuvant made by GSK. It uses the same technology as Sanofi's Flublok influenza vaccine. [7][8]

  9. Do I need the new COVID booster? Eligibility, side effects ...

    www.aol.com/news/side-effects-covid-vaccine-cdc...

    The newest COVID-19 booster is an updated vaccine that targets the omicron XBB.1.5 variant, which was the dominant strain circulating in the U.S. for most of 2023.